ATE223711T1 - Tts enthaltend ein antioxidans - Google Patents

Tts enthaltend ein antioxidans

Info

Publication number
ATE223711T1
ATE223711T1 AT99902525T AT99902525T ATE223711T1 AT E223711 T1 ATE223711 T1 AT E223711T1 AT 99902525 T AT99902525 T AT 99902525T AT 99902525 T AT99902525 T AT 99902525T AT E223711 T1 ATE223711 T1 AT E223711T1
Authority
AT
Austria
Prior art keywords
antioxidant
ethyl
tts
contain
tts contain
Prior art date
Application number
AT99902525T
Other languages
English (en)
Inventor
Bodo Asmussen
Michael Horstmann
Kai Koepke
Harry Tiemessen
Original Assignee
Novartis Erfind Verwalt Gmbh
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE223711(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Erfind Verwalt Gmbh, Lohmann Therapie Syst Lts filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE223711T1 publication Critical patent/ATE223711T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT99902525T 1998-01-12 1999-01-08 Tts enthaltend ein antioxidans ATE223711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (1)

Publication Number Publication Date
ATE223711T1 true ATE223711T1 (de) 2002-09-15

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902525T ATE223711T1 (de) 1998-01-12 1999-01-08 Tts enthaltend ein antioxidans

Country Status (26)

Country Link
US (1) US6335031B1 (de)
EP (1) EP1047409B1 (de)
KR (1) KR100569051B1 (de)
CN (1) CN1129427C (de)
AT (1) ATE223711T1 (de)
AU (1) AU745661B2 (de)
BR (1) BR9906920A (de)
CA (1) CA2315784C (de)
CZ (1) CZ300598B6 (de)
DE (1) DE69902875T2 (de)
DK (1) DK1047409T3 (de)
ES (1) ES2184408T3 (de)
GB (1) GB9800526D0 (de)
HK (1) HK1034036A1 (de)
HU (1) HU227159B1 (de)
ID (1) ID27503A (de)
IL (1) IL137100A (de)
MX (1) MXPA00006438A (de)
NO (1) NO328390B1 (de)
NZ (1) NZ505650A (de)
PL (1) PL201328B1 (de)
PT (1) PT1047409E (de)
RU (1) RU2219926C2 (de)
SK (1) SK284622B6 (de)
TR (2) TR200001688T2 (de)
WO (1) WO1999034782A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1406126A (zh) 1998-10-01 2003-03-26 诺瓦提斯公司 新型缓释口服制剂
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
CA2396686C (en) * 1999-11-29 2008-07-08 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic systems having improved stability and their production
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US9186411B2 (en) * 2008-07-28 2015-11-17 Takeda Pharmaceutical Company Limited Pharmaceutical composition
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
AU2010335309B2 (en) 2009-12-22 2015-08-20 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
SG187158A1 (en) 2010-07-21 2013-02-28 3M Innovative Properties Co Transdermal adhesive compositions, devices, and methods
PT2468274E (pt) 2010-12-14 2015-09-21 Acino Ag Sistema terapêutico transdérmico para a administração de uma substância ativa
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
WO2012161489A2 (ko) 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (de) 2011-11-18 2013-05-22 Labtec GmbH Zusammensetzung zur transdermalen Verabreichung von Rivastigmin
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
WO2013187451A1 (ja) 2012-06-12 2013-12-19 株式会社 ケイ・エム トランスダーム 貼付剤
US20150209302A1 (en) * 2012-09-03 2015-07-30 Nipro Patch Co., Ltd. Adhesive skin patch
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
EP3129012A4 (de) * 2014-04-08 2017-10-11 Teikoku Pharma USA, Inc. Transdermale rivastigminzusammensetzungen und verfahren zur verwendung davon
WO2015174502A1 (ja) 2014-05-15 2015-11-19 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
AU5716898A (en) * 1997-01-08 1998-08-03 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP0952826B1 (de) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung

Also Published As

Publication number Publication date
DK1047409T3 (da) 2002-12-30
SK284622B6 (sk) 2005-08-04
TR200001688T2 (tr) 2000-11-21
HK1034036A1 (en) 2001-10-12
DE69902875T2 (de) 2003-05-22
AU745661B2 (en) 2002-03-28
CA2315784A1 (en) 1999-07-15
NO20003472L (no) 2000-08-07
WO1999034782A1 (en) 1999-07-15
EP1047409A1 (de) 2000-11-02
BR9906920A (pt) 2000-10-10
CZ300598B6 (cs) 2009-06-24
HUP0004300A3 (en) 2003-05-28
KR20010033072A (ko) 2001-04-25
CN1129427C (zh) 2003-12-03
JP3820103B2 (ja) 2006-09-13
EP1047409B1 (de) 2002-09-11
PT1047409E (pt) 2002-12-31
RU2219926C2 (ru) 2003-12-27
NZ505650A (en) 2002-10-25
SK10532000A3 (sk) 2000-11-07
GB9800526D0 (en) 1998-03-11
PL201328B1 (pl) 2009-03-31
JP2002500178A (ja) 2002-01-08
MXPA00006438A (es) 2003-07-21
TR200101021T2 (tr) 2002-06-21
HU227159B1 (en) 2010-09-28
US6335031B1 (en) 2002-01-01
DE69902875D1 (de) 2002-10-17
CZ20002557A3 (cs) 2000-10-11
CN1288375A (zh) 2001-03-21
NO20003472D0 (no) 2000-07-05
NO328390B1 (no) 2010-02-08
AU2278599A (en) 1999-07-26
CA2315784C (en) 2006-06-27
ES2184408T3 (es) 2003-04-01
PL341347A1 (en) 2001-04-09
ID27503A (id) 2001-04-12
IL137100A0 (en) 2001-06-14
KR100569051B1 (ko) 2006-04-10
IL137100A (en) 2004-12-15
HUP0004300A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
ATE223711T1 (de) Tts enthaltend ein antioxidans
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
TR200502189T1 (tr) Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
ATE288256T1 (de) Dermale zusammensetzungen
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
BR0107869A (pt) Composições farmacêuticas eletrogiradas
MA25681A1 (fr) Systeme d'administration de compositions orales de soins comprenant une resine d'organosiloxane utilisant une bandelette de soutien amovible.
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
BRPI0510422A (pt) formulação cosmética transparente à base de microemulsões contendo um ácido alfa-hidroxicarboxìlico
ES2160163T3 (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
EP1300143A4 (de) Pflaster mit 4-biphenylessigsäure
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
BR0313177A (pt) Administração oral de calcitonina
DK0768896T3 (da) Lavdoserede steroidtabletter, der indeholder gallussyreestere som antioxidant, fremgangsmåde til fremstilling og anvendelse
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification